Atara Biotherapeutics Inc. Common Stock
ATRAUnited States
5 filed reports · 258 financial concepts · 4 earnings calls · 0 media appearances
Filed reports
5 reports · Jun 2025 to Jun 2026Each report counts once it has at least one extracted financial fact.
| Report type | Reports | Facts | Periods |
|---|---|---|---|
| Quarterly · 10-QSEC EDGAR | 4 | 927 | Jun 2025 to Jun 2026 |
| Annual · 10-KSEC EDGAR | 1 | 630 | Dec 2025 |
Financial data
258 concepts · 1,557 factsEach concept is one reported line item or metric. The count is how many values of it are held, across the periods shown.
Financial256 concepts · 1,547 facts · Dec 2022 to Jun 2026
- Adjustments to additional paid in capital sharebased compensation requisite service period recognition value12 · Mar 2024 to Jun 2026
- Net income loss12 · Mar 2024 to Jun 2026
- Other comprehensive income unrealized holding gain loss on securities arising during period net of tax12 · Mar 2024 to Jun 2026
- Restructuring Liability12 · Jun 2025 to Dec 2025
- Stockholders equity (US GAAP)12 · Mar 2024 to Jun 2026
- Allocated share based compensation expense11 · Jun 2024 to Jun 2026
- Cash cash equivalents restricted cash and restricted cash equivalents11 · Jun 2024 to Jun 2026
- Commercialization revenue11 · Jun 2024 to Jun 2026
- Comprehensive income net of tax11 · Jun 2024 to Jun 2026
- Cost of commercialization revenue11 · Jun 2024 to Jun 2026
- Costs and expenses11 · Jun 2024 to Jun 2026
- Effect of dilutive securities11 · Jun 2024 to Jun 2026
- Finance lease interest expense11 · Jun 2024 to Jun 2026
- Finance lease right of use asset amortization11 · Jun 2024 to Jun 2026
- General and administrative expense (US GAAP)11 · Jun 2024 to Jun 2026
- Income tax expense benefit11 · Jun 2024 to Jun 2026
- Interest expense (US GAAP)11 · Jun 2024 to Jun 2026
- Interest income operating11 · Jun 2024 to Jun 2026
- Medical and safety expenses11 · Jun 2024 to Jun 2026
- Operating income loss11 · Jun 2024 to Jun 2026
- Operating lease cost11 · Jun 2024 to Jun 2026
- Operating lease weighted average discount rate percent11 · Jun 2024 to Jun 2026
- Other nonoperating income expense11 · Jun 2024 to Jun 2026
- Other operating income expense net11 · Jun 2024 to Jun 2026
Product2 concepts · 10 facts · Sep 2025 to Jun 2026
- Deferred income addition5 · Sep 2025 to Jun 2026
- Deferred income revenue recognized5 · Sep 2025 to Jun 2026
Segments
10 factsFigures broken down by business line, region, product or another axis the company reports on.
Product or service1 member · 10 facts
- Commercialization Revenue10 · Sep 2025 to Jun 2026
Text from filings
Management commentary and risk factors, extracted from SEC filings only.
No commentary or risk-factor text for this company.
Earnings calls
4 calls · May 2022 to Nov 2023Transcripts with management claims and analyst questions, one per fiscal period.
- FY2023 Q3Nov 4, 2023
- FY2022 Q3Nov 8, 2022
- FY2022 Q2Aug 8, 2022
- FY2022 Q1May 5, 2022
Executive media
Podcasts, interviews and conference appearances by the company's executives, with their claims.
No media appearances for this company.
Reports are counted as filed reports with at least one served fact. Counts are read from the database (last read Oct 16, 2026) and refreshed every few hours.